Proton Partners International
Proton Partners International is at the vanguard of advancing cancer care in the UK, building a network of oncology centres known as the Rutherford Cancer Centres.
The Rutherford Cancer Centres are at the forefront of providing innovative care for cancer patients. The centres will provide an all-encompassing cancer service, delivering high energy proton beam therapy, imaging, chemotherapy, radiotherapy, immunotherapy and a range of supportive care services.
Proton beam therapy is a highly-targeted type of radiotherapy that can treat hard-to-reach cancers, such as spinal tumours (chordomas), with a lower risk of damaging the surrounding tissue and causing side effects.
The first centre, in Newport, South Wales, has already opened to receive patient referrals for chemotherapy and radiotherapy, and it will be the first centre in the UK to offer high energy proton beam therapy in 2018. Centres in Northumberland, Reading and Liverpool and also under development.
The services provided through the Rutherford Cancer Centres will be available to insured private patients, self-paying patients and NHS patients. Proton Partners International has partnered with world-leading providers to equip each centre with the very latest cancer technology.
We are committed to improving cancer care and work with universities and technology partners to support research into proton beam therapy. Rutherford Innovations will lead and coordinate research activity involving all our partners at regional, national and international levels.
For more information on the Rutherford Cancer Centres, please visit www.therutherford.co.uk